Chemical Business Newsbase articles from December 2000

Chemical Business Newsbase archives from December 2000

CHEMICAL WEEKLY: Morepen eyes US nod for three bulk drugs.
December 19, 2000... Morepen Laboratories (Morepen) plans to obtain approval from the US Food and Drugs Administration for its three new bulk drugs: zafirlukast - an antiasthmatic, atorvastatin - a cholesterol-lowering agent, and fexofenadine - an anti-allergic....

CHEMICAL WEEKLY: Wockhardt, German firm pull out Core Healthcare bids.
December 19, 2000... Wockhardt and Fresenious Kabi AG, a German Intravenous fluid major, have decided to withdraw their respective bids to acquire controlling stake in the financially unviable and BIFR referred Core Healthcare. With this, the financial...

CHEMICAL WEEKLY: Production of phosphatic fertilizers up 15% in 1H 2000-2001. [2 tables].
December 19, 2000... Fertilizer production in India increased by 5.4% during Sep 2000 and by 5.3% during 1H ended Sep 2000. India produced 5,449,600 tonnes of nitrogenous fertilizer and 1.878 M tonnes of phosphatic fertilizer during 1H 2000-2001 (+2.4% over...

CHEMICAL WEEKLY: 'Farmer-friendly fertilizer policy is Centre's intention'.
December 19, 2000... The Minister for Chemicals and Fertilisers said that the Government of India is considering the draft on the fertilizer policy and would soon come out with "farmer friendly" guidelines. The Minister is yet to consult all the State...

CHEMICAL WEEKLY: HAL working on development of new miticide.
December 19, 2000... Hindustan Antibiotics Ltd (HAL) is developing an effective miticide to combat Erophyd, a coconut mite, currently widespread in the parts of Tamil Nadu and Kerala. The new product has completed its lab tests and field demonstrations and...

CHEMICAL WEEKLY: Excel Industries bottomline drops to Rup 60 M in 1H 2000-2001.
December 19, 2000... Excel Industries has recorded a profit of Rup 63 M and a total income of Rup 2.14 bn during 1H ended Sep 2000 (net profit of Rup 173.5 M and a total income of Rup 2.48 bn in 1H ended Sep 1999). According to the company official, the...

CHEMICAL WEEKLY: RPG group may hive-off agrochem business.
December 19, 2000... RP Goenka group has planned to spin-off the agrochemicals division of RPG Life Sciences into a separate company. The group is currently seeking for a joint venture partner and is ready to offer majority stake to the partner in the new...

CHEMICAL WEEKLY: CCEA nod for HPCL to go it alone in Bhatinda project.
December 19, 2000... Hindustan Petroleum Corp Ltd (HPCL) has received approval from the Cabinet Committee on Economic Affairs (CCEA) to go ahead with the Rup 98.06 bn, 9 M tonne refinery at Bhatinda in Punjab by itself. HPCL had appealed to CCEA seeking...

CHEMICAL WEEKLY: Proposal to set up fertilizer plant in Tunisia on cards.
December 19, 2000... The Government of India and the Government of Tunisia are planning to set up a fertilizer plant in Tunisia as a 50:50 joint venture.

CHEMICAL WEEKLY: Crude throughput up 29% for 1H 2000-2001. [1 table].
December 19, 2000... India recorded an increase of 29% in crude throughput to 50.466 M tonnes during 1H ended Sep 2000 at a capacity utilization of 89.4%. During Jul 2000, crude oil imports increased 95% to $1529 M. Indian Oil Corp recorded a crude...

DAGENS INDUSTRI: Astra Zeneca to introduce Nexium in 20 countries.
December 19, 2000... During 2001 Astra Zeneca will launch Nexium in around 20 countries. In 2Q 2001 it will submit an application for registration of its statin Crestor and during 2001 an applications will be submitted for the registration of Faslodex in the...

DAGENS INDUSTRI: Diamyd to launch vaccine in 2006.
December 19, 2000... Diamyd Medical, Sweden, predicts that its GAD-based diabetes vaccine Diamyd will be on the market by 2006. This is later than had been forecast earlier because Phase II studies are taking longer than anticipated. These studies are...

HET FINANCIEELE DAGBLAD: Nyloplast to sell US operations.
December 19, 2000... The Dutch plastics manufacturer Nyloplast is to sell off the loss-making Nyloplast America, which is based at Salt Lake City and Atlanta. This should generate an accounting loss. Excluding the operating losses from these businesses...

HET FINANCIEELE DAGBLAD: Nuon takes over Norit.
December 19, 2000... The Dutch energy company Nuon is acquiring more than 95% of the shares in Norit (active carbon and water purification). It has already secured 84% of the shares through an agreement with Gilde. Original text in DUTCH

DAGENS NAERINGSLIV: Elkem wants shares in Olivin.
December 19, 2000... Elkem is said to be interested in acquiring the 49% of shares in the minerals company Olivin that are up for sale for an estimated NKR 200 M. North Cape Minerals and a local group of investors are also said to be interested. ...

HET FINANCIEELE DAGBLAD: Huhtamaki to close Groenlo packaging plant.
December 19, 2000... The Finnish packaging company Huhtamaki Van Leer is planning to close its facility at Groenlo, Netherlands, midway through 2001. Around 230 jobs are therefore under threat at the plant which produces and labels plastic containers. It...

PRESS RELEASE: Copene sale to change Brazil's petrochemical landscape.
December 19, 2000... The auction of Companhia Petroquimica do Nordeste (Copene), which includes the sale of assets Politeno, Polialden and Proppet in the Camacari, Brazil's largest petrochemical compound, will change Brazil's petrochemical landscape. The...

PRESS RELEASE: Copene sale affects petrochemical balance of power.
December 19, 2000... The president of the Mariani group, one of the majority investors in Copene, does not believe the sale of the company in an auction scheduled for 14 Dec 2000 will affect competitors based in the Triunfo and the Maua compounds. But recent...

PRESS RELEASE: FDA approves Elan's Myobloc (Botulinum Toxin Type B) Injectable Solution.
December 19, 2000... Elan Corp plc announced that the US Food and Drug Administration (FDA) approved Myobloc (Botulinum Toxin Type B) Injectable Solution for the symptomatic treatment of patients with cervical dystonia (CD) to reduce the severity of abnormal head...

PRESS RELEASE: MorphoSys announces milestone in collaboration with Roche.
December 19, 2000... MorphoSys AG announced the achievement of the first milestone in their collaboration with Roche on Human Combinatorial Antibody Library (HuCAL) derived medications for the treatment of Alzheimer's Disease. This achievement triggers an...

PRESS RELEASE: Quidel Corp completes acquisition of Litmus Concepts.
December 19, 2000... Quidel Corp announced the completion of its acquisition of Litmus Concepts Inc, a privately held in vitro diagnostic company focused on the development and manufacture of unique diagnostic products for women's health. The acquisition...

PRESS RELEASE: Generex Biotechnology opens newly expanded manufacturing facility and analytical lab.
December 19, 2000... Generex Biotechnology Corp (Generex) officially opened its newly expanded manufacturing facility and analytical laboratory in Toronto, Canada. The facility has been designed, equipped and staffed to conform with Good Manufacturing...

PRESS RELEASE: Aventis Pasteur completes shipment of all doses of influenza vaccine ordered by its customers.
December 19, 2000... Aventis Pasteur has completed shipment of all doses of Fluzone influenza vaccine ordered by its customers. In addition, the company is currently producing another 9 M doses under a contract with the Centers for Disease Control and...

PRESS RELEASE: Zicam Cold Remedy secures distribution at GNC and Vitamin World stores in the US.
December 19, 2000... Gel Tech LLC, a joint venture between Gum Tech International Inc and BioDelivery Technologies Inc, announced an agreement to distribute Zicam Cold Remedy to General Nutrition Companies (GNC) and Vitamin World nutrition stores in the US,...

PRESS RELEASE: C Sixty enters upscale manufacturing phase for fullerene based anti-HIV drug for patients with AIDS.
December 19, 2000... William Multi-Tech Inc, (Multi-Tech) announced that C Sixty Inc, a privately held biotechnology company, in which Multi-Tech has a 40% ownership interest, has begun upscale manufacturing of its lead fullerene based drug candidate for...

PRESS RELEASE: SYN X Pharma Inc and National Research Council sign agreement on heart failure research.
December 19, 2000... The National Research Council of Canada and SYN X Pharma (SYN X) have signed an agreement to support the development of a diagnostic test for congestive heart failure (CHF). Through the Industrial Research Assistance Program, the...

PRESS RELEASE: Flu vaccine shortage is due to low price not manufacturing problems; no financial incentive for manufacturers.
December 19, 2000... Contrary to numerous reports, the shortage of flu vaccine is not due to manufacturing problems and plant shutdowns according to a recent study by The Webster Consulting Group. The real culprit is the vaccine's low price. The whole...

PRESS RELEASE: Delsys receives three new patents for electrostatic deposition technology.
December 19, 2000... Delsys Pharmaceutical Corp (Delsys) has been awarded three new patents, strengthening the company's intellectual property ownership for electrostatic deposition processes for the development and manufacture of pharmaceutical and diagnostic...

PRESS RELEASE: LifePoint files a 'composition and methods' patent for the synthesis of novel tracers for detecting amphetamine and methamphetamine.
December 19, 2000... LifePoint Inc announced the filing of a patent containing 13 claims for the synthesis of novel components whose use not only improves the performance of the flow immunosensor technology, but also decreases the cost at which new tests can be...

PRESS RELEASE: Amended Needlestick Safety and Prevention Act underscores value of NeedleSafe II as promotional item for medical community.
December 19, 2000... The recent passage of the amended Needlestick Safety and Prevention Act by the US Congress - which mandates workplace engineering controls to prevent accidental needle sticks - strongly accentuates both the usefulness and unique promotional...

PRESS RELEASE: Epimmune presents data on its multi-epitope vaccine to treat breast, colon and lung cancers.
December 19, 2000... Epimmune Inc reported results at the 9th International Conference on Gene Therapy of Cancer showing that its therapeutic vaccine designed to treat breast, colon and lung cancers stimulates strong immune responses in animal models and using...

PRESS RELEASE: Merger of Shire Pharmaceuticals Group plc with Biochem Pharma Inc to form a leading global speciality pharmaceutical company. [3 tables].
December 19, 2000... Shire Pharmaceuticals Group plc (Shire) and BioChem Pharma Inc (BioChem) have entered into an agreement to merge the two groups to form a leading global speciality pharmaceutical company. The Merger will be achieved through exchange of...

PRESS RELEASE: Glaxo Wellcome's Malarone recommended for the prevention and treatment of malaria.
December 19, 2000... The Centers for Disease Control and Prevention (CDC) in Atlanta recently changed its recommendation on malaria to include Glaxo Wellcome Inc's Malarone (atovaquone and proguanil hydrochloride) as another option for the prevention and...

PRESS RELEASE: Xanthon Inc selects Perkins & Will to provide planning and design for their new facility.
December 19, 2000... Xanthon Inc announced that the Research Triangle Park office of Perkins & Will, in conjunction with CRB Engineers, has been selected to provide planning and architectural design for their proposed new facility. The estimated 80,000 sq ft...

PRESS RELEASE: DSM, PolyOne and Solvay acquire equity in Omnexus.
December 19, 2000... DSM Engineering Plastics Inc, PolyOne and Solvay, announced earlier in 2000 as suppliers for Omnexus, have now acquired an equity stake in the B2B plastics marketplace and have attained the rank of Leadership Suppliers, joining founding...

PRESS RELEASE: Merck & Co Inc and probiodrug GmbH sign exclusive worldwide licensing arrangement.
December 19, 2000... Merck & Co Inc and probiodrug Gesellschaft fur Arzneimittelforschung mbH, Halle/Saale, Germany announced have signed a licensing agreement that gives Merck certain exclusive worldwide rights to probiodrug's proprietary dipeptidyl peptidase...

PRESS RELEASE: Amarin announces initiation of Phase III study of LAX-101 for the treatment of Huntington's disease.
December 19, 2000... Amarin Corp plc has been notified by Laxdale Ltd that the US Food and Drug Administration has cleared the Investigational New Drug (IND) application for LAX-101 for the treatment of Huntington's disease. The pivotal, double-blind, placebo...

PRESS RELEASE: Rapamune receives unanimous positive opinion from the European Medicines Evaluation Agency (EMEA).
December 19, 2000... Wyeth-Ayerst Pharmaceuticals, a division of American Home Products Corp, announced that Rapamune (sirolimus), a novel immunosuppressive agent developed for the prevention of organ rejection following renal transplantation, has received a...

PRESS RELEASE: Atacand (candesartan cilexetil) combined with Zestril (lisinopril) effectively reduced blood pressure in hypertensive Type 2 diabetic patients.
December 19, 2000... A study published in the 9 Dec 2000 issue of the British Medical Journal (BMJ) reports that AstraZeneca's angiotensin II receptor blocker (ARB) Atacand (candesartan cilexetil) together with its angiotensin converting enzyme (ACE) inhibitor...

PRESS RELEASE: National Cancer Institute and Biovest International consider cooperative development of vaccines for B-cell lymphomas.
December 19, 2000... Biovest International has entered negotiations with the National Cancer Institute (NCI) for a Cooperative Research and Development Agreement (CRADA) for the study of an idiotype tumour vaccine against non-Hodgkin's B-cell lymphoma. The...

PRESS RELEASE: Focal exercises third investment commitment from Genzyme Surgical Products, providing $5 M in funding.
December 19, 2000... Focal Inc announced that, as per the terms of a previously announced sales, marketing and financing agreement between the company and Genzyme Surgical Products (Genzyme), it has exercised its option to have Genzyme purchase about 2.4 M shares...

PRESS RELEASE: Praxis Pharmaceuticals receives A$ 3.4 M grant.
December 19, 2000... Praxis Pharmaceuticals Inc announced that its subsidiary, Praxis Pharmaceuticals Australia Pty Ltd (Praxis Australia), has been offered A$ 3.4 M Commonwealth Government R&D START Grant to strengthen and accelerate its multiple sclerosis...

PRESS RELEASE: Terra Industries sells portion of its Dec 2000 natural gas, curtails production.
December 19, 2000... Terra Industries Inc (Terra) has sold a portion of its Dec 2000 natural gas purchases. This sale required the shutdown of one of the two sets of ammonia and upgrading plants at its Verdigris, OK facility. The company will evaluate...

PRESS RELEASE: Dystonia Foundation applauds FDA approval of Elan Corp's Myobloc.
December 19, 2000... The Dystonia Medical Research Foundation proclaimed the US Food and Drug Administration's (FDA) decision to approve Myobloc (botulinum toxin type B) Injectable Solution as an advance in the symptomatic treatment of patients with cervical...

PRESS RELEASE: Healthcare Technologies' subsidiaries Savyon & Gamidagen to merge: merged entity to reverse-merge with Selector Ltd.
December 19, 2000... Healthcare Technologies Ltd (Healthcare) announced that its fully owned subsidiary, Savyon Diagnostics Ltd, and its recently acquired subsidiary, GamidaGen Ltd, will merge under the Savyon name by the end of 1Q 2001. Furthermore, it has...

PRESS RELEASE: Williams, Dailey & O'Leary: According to Yale University researchers unexplained strokes linked to diet pill and cold remedy ingredient.
December 19, 2000... A study conducted by Yale University found that women who take phenylpropanolamine (PPA), an ingredient found in many over-the-counter diet drugs and cold medications, increased the risk of stroke 17 times among younger women who had taken...

PRESS RELEASE: Orphan Medical obtains additional indication for Antizol (fomepizole) Injection for the treatment of methanol poisoning.
December 19, 2000... Orphan Medical Inc announced that the Food and Drug Administration (FDA) has given clearance to market Antizol (fomepizole) Injection for the treatment of methanol poisoning, or for use in suspected methanol ingestion, either alone or in...

PRESS RELEASE: Synaptic Pharmaceutical awarded patent for the alpha adrenergic 1B and 1D receptors.
December 19, 2000... Synaptic Pharmaceutical Corp has been awarded a US patent (6,156,518) for the use of the alpha adrenergic 1B and 1D receptors to screen compounds that bind to them. The alpha adrenergic patent estate now includes the screening claims for...

PRESS RELEASE: Sybron International Corp announces completion of spin-off.
December 19, 2000... Sybron International Corp has completed the distribution (or spin-off) to its shareholders of the common stock and related preferred stock purchase rights of Sybron Dental Specialties Inc (Sybron Dental). As previously announced,...

PRESS RELEASE: Advanced Process Technologies Inc announces a name change to Integrated Pharmaceuticals Inc.
December 19, 2000... Advanced Process Technologies Inc announced a name change of the company to Integrated Pharmaceuticals Inc. The name change is anticipated to take effect from 12 Dec 2000. Advanced Process Technologies Inc is a biopharmaceutical...

PRESS RELEASE: Terra Nitrogen Co LP sells portion of its Dec 2000 natural gas, curtails production.
December 19, 2000... Terra Nitrogen Co LP has idled for Dec 2000 its Blytheville, AR facility and one half of its Verdigris, OK facility due to the sudden and unexpected increase in natural gas prices. The costs to maintain these facilities during Dec 2000...

PRESS RELEASE: Earth Sciences reaches settlement with Hongkong Bank.
December 19, 2000... Earth Sciences Inc has reached an agreement in principle with the Hongkong Bank of Canada (HSBC) to settle about $400,000 of debt in default. The indebtedness arose from operations at the Earth Sciences Calgary chemical plant that was...

PRESS RELEASE: Air Products boosts global SiF4 capacity to meet increasing semiconductor and fibre optic processing demand.
December 19, 2000... In an effort to meet increasing demand for electronic speciality gases used in semiconductor and fibre optic processing applications, Air Products and Chemicals Inc (Air Products) is making additional investments to expand its global silicon...

PRESS RELEASE: Lukoil completes tender offer for Getty Petroleum Marketing Inc.
December 19, 2000... OAO Oil Co Lukoil (Lukoil) announced that its subsidiary Mikecon Corp had successfully completed its $5.00/share tender offer for all of the outstanding shares of common stock of Getty Petroleum Marketing Inc (Getty Petroleum). The...

PRESS RELEASE: Serono and Vertex establish collaboration to develop and market caspase inhibitors for the treatment of neurological and inflammatory diseases.
December 19, 2000... Serono SA and Vertex Pharmaceuticals Inc (Vertex) have entered into a collaboration to discover, develop, and market caspase inhibitors. Under the terms of the agreement, Vertex could receive up to $95 M to support and expand Vertex's...

PRESS RELEASE: Cancer researcher develops synthetic melanin formulated into cosmetic foundation that self-adjusts, protects against sun damage.
December 19, 2000... A leading skin cancer researcher at Yale University School of Medicine has developed a synthetic melanin that has been formulated into a cosmetic foundation that self-adjusts to skin tone while protecting against sun damage. Called...

PRESS RELEASE: Leading dairy and meat companies 'just say no' to antibiotics after FDA proposes ban on two antibiotics used on farm animals.
December 19, 2000... In light of recent news that the Food and Drug Administration (FDA) plans to ban the use of two antibiotics, Baytril and SaraFlox (both classified as flouroquinolones) used by livestock and poultry farmers, Horizon Organic Dairy, Applegate...

PRESS RELEASE: Diversa announces its entry into a drug discovery research collaboration with Glaxo Wellcome.
December 19, 2000... Diversa Corp has entered into a drug discovery research collaboration with Glaxo Research and Development Ltd, a wholly owned subsidiary of Glaxo Wellcome plc, to identify pharmaceuticals derived from Diversa's recombinant multi-gene...

PRESS RELEASE: Glaxo Wellcome and SmithKline Beecham merger update: Completion planned for 27 Dec 2000.
December 19, 2000... Glaxo Wellcome and SmithKline Beecham announce that very significant progress has been made towards completion of their merger to form GlaxoSmithKline. The companies have reached agreement with the Staff of the US Federal Trade...

PRESS RELEASE: SmithKline Beecham terminates clinical trial of lotrafiban.
December 19, 2000... SmithKline Beecham has terminated clinical investigation of lotrafiban, an experimental cardiovascular drug. Lotrafiban was in a Phase III study to evaluate its utility in preventing recurrent strokes and heart attacks. SmithKline...

PRESS RELEASE: Paradigm Genetics discovers 100th herbicide target.
December 19, 2000... Paradigm Genetics Inc has announced the discovery and genetic validation of its 100th novel herbicide target for high-throughput chemical screening. This achievement is a significant increase over conventional discovery and validation...

PRESS RELEASE: Results of Markman hearing narrows GenSci-Osteotech case.
December 19, 2000... GenSci OrthoBiologics Inc (GenSci), a subsidiary of GenSci Regeneration Sciences Inc, announced that a federal district court in Los Angeles issued its ruling on GenSci's requested Markman hearing to define specific patent terms in the patent...

PRESS RELEASE: Goodyear says four better than two.
December 19, 2000... While some motorists believe they can save a bundle this season by buying two winter tyres rather than four, Goodyear Tire & Rubber Co officials recommend that four winter tyres are preferable to two. Goodyear market research shows 60% of...

PRESS RELEASE: Angstrom Pharmaceuticals announces the award of an SBIR grant from the NCI to develop its proprietary uPAR antagonist, A36.
December 19, 2000... Angstrom Pharmaceuticals Inc has received a prestigious NIH Small Business Innovative Research Grant (SBIR) from the National Cancer Institute (NCI) to develop A36, its proprietary antagonist of the urokinase plasminogen activator receptor...

PRESS RELEASE: Empyrean Bioscience receives order from Weis Markets for Preventx Hand Sanitizer and First-Aid Antiseptic.
December 19, 2000... Empyrean Bioscience Inc received its first purchase order for its new line of alcohol-free Preventx Hand Sanitizer and First-Aid Antiseptic products from Weis Markets, a large regional grocery chain with more than 160 store locations in six...

PRESS RELEASE: Concerta now to be available in three doses.
December 19, 2000... Alza Corp announced that the US Food & Drug Administration has approved a 54 mg tablet of Concerta (methylphenidate HCl) extended-release tablet (CII), now providing physicians with three dosage strengths of Concerta for the treatment of...

PRESS RELEASE: Calydon announces issuance of three patents for technologies that destroy cancer tumours, including prostate cancer.
December 19, 2000... The US Patent and Trade Office has granted Calydon Inc three patents that significantly expand the company's intellectual property in the area of engineering tumour-specific viruses to replicate in and kill prostate cancer cells. Issued...

PRESS RELEASE: Merck cites strong growth in presentation to analysts.
December 19, 2000... Merck & Co Inc has created a strong platform for growth and is delivering outstanding performance. The company has made significant investments in those areas that can enable it to achieve its goal to be a top-tier growth company over...

PRESS RELEASE: Study shows fewer patients reported side effects with the mood stabilizer Depakote than the antipsychotic olanzapine.
December 19, 2000... Data from a head-to-head study showed fewer patients reported side effects with the mood stabilizer, Depakote (divalproex sodium delayed-release tablets), compared to patients taking the Zyprexa (antipsychotic olanzapine) of Eli Lilly,...

PRESS RELEASE: Southern BioSystems Inc (SBS) announces microencapsulation collaboration with Alcon.
December 19, 2000... Southern BioSystems Inc (SBS) has entered into an agreement with Alcon to develop controlled-release products for certain ophthalmic indications. Under the agreement, Alcon will have exclusive access to SBS' proprietary...

PRESS RELEASE: Federal Court upholds Osteotech's patent interpretation in case against GenSci.
December 19, 2000... Osteotech Inc announced that the US District Court for the Central District of California has adopted Osteotech's interpretation of claims in two patents asserted by Osteotech against GenSci Orthobiologics Inc (GenSci). In this lawsuit,...

PRESS RELEASE: Quest Diagnostics and Stanford University researchers identify new mutation of antiviral-resistant HIV.
December 19, 2000... Quest Diagnostics Inc announced that its researchers, in collaboration with the Center for AIDS Research at Stanford University School of Medicine, have identified a new mutation of HIV-1 that is associated with reduced susceptibility to...

PRESS RELEASE: Dow AgroSciences and Cheminova to form joint venture.
December 19, 2000... Dow AgroSciences LLC and Cheminova A/S have agreed to form a 50:50 joint venture to register and market a premium pyrethroid insecticide. The new Zurich- based company, Pytech Chemicals GmbH, will develop products with superior efficacy...

PRESS RELEASE: NPS Pharmaceuticals announces clinical testing of calcilytics by its partner SmithKline Beecham; milestone payment earned.
December 19, 2000... NPS Pharmaceuticals Inc (NPS) announced that its corporate partner, SmithKline Beecham (SB) has begun clinical testing with calcilytics for treating osteoporosis. As a result, NPS has earned a $1 M milestone payment under the terms of...

PRESS RELEASE: Vysis' HER-2 DNA probe test for breast cancer cited in Journal of Clinical Oncology article.
December 19, 2000... Vysis Inc announced that an article published in the Nov 2000 issue of the Journal of Clinical Oncology highlights the assessment of HER-2 status in breast cancer using Vysis' proprietary fluorescence in situ hybridization (FISH) technology....

PRESS RELEASE: Pennsylvania Gov Ridge administration awards more than $2.3 M to clean up tyre piles.
December 19, 2000... On behalf of Pennsylvania Gov Tom Ridge, Department of Environmental Protection (DEP) Secretary James M Seif announced that DEP is awarding more than $2.3 M to clean up tyre piles throughout the Commonwealth. The money will help pay to...

PRESS RELEASE: CeNeS Pharmaceuticals plc shareholders approve acquisition of Cambridge NeuroScience Inc.
December 19, 2000... Cambridge NeuroScience Inc announced that the shareholders of CeNeS Pharmaceuticals plc (CeNeS), at their special meeting on 8 Dec 2000, voted to approve the proposed acquisition of Cambridge NeuroScience. The merger was first announced...

PRESS RELEASE: Lawter forms JV with Chinese company.
December 19, 2000... Eastman Chemical Co announced that its wholly-owned subsidiary, Lawter International (Lawter) has formed a Chinese-foreign equity joint venture company with Funing County Organic Chemical Factory of the People's Republic of China. The...

PRESS RELEASE: Alcan announces acquisition of 30% of Gove alumina refinery, issues 4Q 2000 earnings warning and announces higher merger synergies.
December 19, 2000... Alcan Aluminium Ltd (Alcan) announces that it will acquire 30% of the Gove alumina refinery and related bauxite mine at a cost of $393 M. The company already owns 70% of these assets, which have a total capacity of 1.8 M tonnes/y of...

PRESS RELEASE: IdaTech and Tokyo Boeki join to manufacture and market fuel cells in Japan, Asia.
December 19, 2000... IdaTech, a subsidiary of Idacorp announced the execution of a long-term licence and distribution agreement for its patented fuel cell systems with Tokyo Boeki Ltd, a Japanese corporation. Tokyo Boeki also took a minority equity position...

PRESS RELEASE: Premcor starts new coker unit at Port Arthur refinery.
December 19, 2000... Premcor Inc announced that it is currently in the start-up process for its newly constructed 80,000 bbls/day coker unit at its Port Arthur, TX, refinery. The coker unit was started on 30 Nov and is currently averaging nearly 50,000...

PRESS RELEASE: Arthur Andersen says all is set for Copene sale on 14 Dec 2000.
December 19, 2000... Auditing firm Arthur Andersen in Sao Paulo has said that all is set for the auction of Copene, a petrochemical which will go on the auction block on 14 Dec 2000. Three are the interested buyers, Dow Chemical of the US, Brazil's Ultra...

PRESS RELEASE: Praecis Pharmaceuticals Inc announces submission of new drug application for prostate cancer.
December 19, 2000... Praecis Pharmaceuticals Inc (Praecis) announced the submission to the US Food and Drug Administration (FDA) of a New Drug Application (NDA) for abarelix depot, the first in a new class of prostate cancer drugs that avoids stimulating the...

PRESS RELEASE: Myriad Genetics and Bayer Corp extend proteomics collaboration through 31 Dec 2002.
December 19, 2000... Myriad Genetics Inc (Myriad) announced that it has extended its proteomics collaboration with Bayer Corp through 31 Dec 2002. This highly productive research programme, using Myriad's ProNet technology, has already discovered six...